Preliminary reports indicate conolidine might inhibit unique ion channels, lessening neuronal excitability and restricting discomfort signals. This system is especially appropriate in neuropathic soreness, wherever irregular signaling triggers persistent pain. In addition, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integr